title: Underexplored Opportunities for Natural Products in Drug Discovery.
abstract: The importance of natural products in the treatment of human disease is well documented. While natural products continue to have a profound impact on human health, chemists have succeeded in generating semisynthetic analogues that sometimes overshadow the original natural product in terms of clinical significance. Synthetic efforts based on natural products have primarily focused on improving their drug-like features while targeting utility in the same biological space. A less documented phenomenon is that natural products can serve as powerful starting materials to generate drug substances with novel therapeutic utility that is unrelated to the biological space of the natural product starting material. In this Perspective, examples of natural product derived marketed drugs with therapeutic utility in clinical space that is different from the biological profile of the starting material are presented, demonstrating that this is not merely a theoretical concept but both a clinical reality and an underexplored opportunity.
authors.affiliation: Janssen Pharmaceutical Companies of Johnson & Johnson , 1400 McKean Road, Spring House, Pennsylvania 19477, United States.
authors.forename: Bart L
authors.initials: BL
authors.lastname: DeCorte
mesh_terms: D001688:Biological Products / Q000138:chemical synthesis* / Q000737:chemistry / Q000627:therapeutic use; D003042:Cocaine / Q000138:chemical synthesis* / Q000737:chemistry / Q000627:therapeutic use; D055808:Drug Discovery; D004958:Estradiol / Q000138:chemical synthesis* / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D008968:Molecular Conformation; D009020:Morphine / Q000138:chemical synthesis* / Q000737:chemistry / Q000627:therapeutic use; D011803:Quinine / Q000138:chemical synthesis* / Q000737:chemistry / Q000627:therapeutic use
chemical_list: D001688:Biological Products; D004958:Estradiol; D009020:Morphine; D011803:Quinine; D003042:Cocaine